Back to Directory Camlin Tierney Email tierney@sdac.harvard.edu Institution Statistical and Data Analysis Center Title Research Scientist Request an Update Affiliated Studies IMPAACT 2052: Safety and pharmacokinetics of an AAV-Vectored broadly neutralizing antibody in infants living with HIV DAIDS Number 39268 Research Area Cure and Immunotherapy Study Status In Development P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women with Hepatitis C with and without HIV DAIDS Number 39052 Research Area Therapeutics Study Status Enrolling Show All
IMPAACT 2052: Safety and pharmacokinetics of an AAV-Vectored broadly neutralizing antibody in infants living with HIV DAIDS Number 39268 Research Area Cure and Immunotherapy Study Status In Development
P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women with Hepatitis C with and without HIV DAIDS Number 39052 Research Area Therapeutics Study Status Enrolling
